NOT FOR PUBLICATION OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA AND JAPAN.
 

SHOP APOTHEKE EUROPE promoted to MDAX.

Venlo, the Netherlands, 21 September 2020. The shares of SHOP APOTHEKE EUROPE are now listed in the MDAX selection index following the latest index review by Deutsche Börse.

With its promotion to the MDAX, SHOP APOTHEKE EUROPE is one of the 60 largest listed companies in Germany which, in terms of market capitalisation and stock exchange turnover, directly follow the stocks included in the DAX.

Since its IPO in October 2016, SHOP APOTHEKE EUROPE has continuously increased its market capitalisation (currently around EUR 2 billion) and share turnover. In September 2018, the company was included in the SDAX. Now, just two years later, it ascends to the MDAX.

CFO Jasper Eenhorst comments on the admission to the MDAX: "We are pleased that our growth story is understood and honoured by the capital market. The admission to the MDAX is both a recognition of our work and an incentive to do even better for us." In addition to its dynamic operational growth in Europe, the progressive development of the company from a pure online pharmacy retailer to a customer-centric e-pharmacy platform has led to an increase in investor interest in the past years.
 

ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is one of the leading and fastest-growing online pharmacies in Continental Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership. The product range for the whole family in the areas of OTC, beauty and personal care products as well as prescription drugs is supplemented by high quality natural food and health products, low carb products and sports nutrition following the acquisition of nu3 GmbH in July 2018.

SHOP APOTHEKE EUROPE operates online pharmacies in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland at this moment. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to over 5.5 million active customers (at the end of Q2 2020) fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016 and has moved up to the MDAX index on 21 September 2020.

In addition to being traded on the Frankfurt stock exchange, SHOP APOTHEKE EUROPE'S convertible bonds (ISIN: DE000A19Y072) are also tradeable on the Dutch Euronext stock exchange, which operates the stock exchanges in Paris, Amsterdam, Brussels and Lisbon.
 

PRESS CONTACTS.

Trade and popular media:
Sven Schirmer
Tel: +49 221 99 53 44 31
Email: presse@shop-apotheke.com

Financial media:
Bettina Fries
Tel: +49 211 75 80 779
Email: presse@shop-apotheke.com

Investor relations:
Carmen Herkenrath
Tel.: +31 77 850 6109
Email: carmen.herkenrath@shop-apotheke.com

Thomas Schnorrenberg
Mobile: +49 151 465 31317
Email: presse@shop-apotheke.com